Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 279, Issue 6 48-6, 2000, Pages

  Kawai, Hiroya ^a   Stevens, Suzanne Y ^a   Liang, Chang Seng ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Noradrenergic nerve endings; Norepinephrine; Tyrosine hydroxylase

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; NORADRENALIN; QUINAPRIL; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; AORTA PRESSURE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FLUORESCENCE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART VENTRICLE REMODELING; HEMODYNAMICS; IMMUNOCYTOCHEMISTRY; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RABBIT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE;

EID: 0034532116     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.279.6.h3012     Document Type: Article

References (46)

1. Angiotensin II production in different vascular beds in hypertensive subjects
2. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations
3. Noradrenergic sympathetic innervation of the spleen. IV. Morphometric analysis in adult and aged F344 rats
4. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
5. 1 receptor
6. Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria
7. Modulatory effect of bradykinin on noradrenaline release in isolated atria from normal and B2 knockout transgenic mice
8. Angiotensin AT1 receptor inhibition in pacing induced heart failure: Effects on left ventricular myocardial collagen content and composition
9. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
10. Standardization of the sucrose-potassium phosphate-glyoxylic acid histofluorescence method for tissue monoamines
11. β-Adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content
12. Characterization of bradykinin receptors mediating catecholamine release in PC12 cells
13. Interactions between the renin-angiotensin system (RAS) and the sympathetic system
14. The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin
15. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure
16. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
17. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure
18. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: Role of bradykinin
19. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure
20. Alterations in cardiac adrenergic terminal function and β-adrenoceptor density in pacing-induced heart failure
21. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure
22. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: Effects on left ventricular performance and regional blood flow patterns
23. 2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons
24. Facilitation of adrenergic transmission in the canine heart by intracoronary infusion of angiotensin II: Effect of prostaglandin synthesis inhibition
25. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial β-adrenoceptor sensitivity in the ferret: Normalization by antioxidants
26. ANG II and baroreflex function in rabbits with CHF and lesions of the area postrema
27. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors
28. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats
29. Inhibitory action of bradykinin on release of the adrenergic transmitter in the isolated lapine kidney
30. Haemodynamic response to induction of anaesthesia with ketamine/midazolam
31. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats
32. Angiotensin II receptor inhibition. A new therapeutic principle
33. Angiotensin II blockade enhances baroreflex control of sympathetic outflow in heart failure
34. Blockade of AT 1 receptors enhances baroreflex control of heart rate in conscious rabbits with heart failure
35. Blockade of the renin-angiotensin system in heart failure in conscious dogs
36. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin
37. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure
38. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
39. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: Differential effects on myocyte contractile processes
40. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. I. Effects on left ventricular performance and neurohormonal system
41. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. II. Effects on myocyte contractile processes
42. 1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure
43. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
44. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
45. Intracoronary infusion of bradykinin: Effects on noradrenaline overflow following reperfusion of ischemic myocardium in the anesthetized dog
46. Angiotensin II-forming pathways in normal and failing human hearts